1 Report Prologue 19
2 Market Introduction 23
2.1 Introduction 23
2.2 Scope of the Study 23
2.2.1 Research Objective 23
2.2.2 Assumptions 23
2.2.3 Limitations 24
2.3 Market Structure 24
3 Research Methodology 27
3.1.1 Primary Research Methodology 28
3.1.2 Secondary Research Methodology 29
3.1.3 Market Share Analysis 30
3.1.4 Trade Analysis 30
3.1.5 Market Pricing Approach 31
4 Market Dynamics 32
4.1 Introduction 32
4.2 Drivers 33
4.2.1 Rise in prevalence rate of diseases demanding endoscopy ( Impact weightage - 35 %) 33
4.2.2 Development of the medical devices contract manufacturing industry (Impact weightage - 20% ) 34
4.2.3 Technological Advancement in Endoscopy ( Impact weightage - 30%) 35
4.2.4 Growing geriatric population will boost the growth of Endoscope device globally ( Impact weightage - 15%) 36
4.3 Restraints 37
4.3.1 Infections and complications caused by endoscopes is hampering the market ( Impact weightage - 60%) 37
4.3.2 Lack of skilled physicians ( Impact weightage - 40%) 38
4.4 Opportunity 39
4.5 Megatrends 39
4.6 Macroeconomic indicators 40
5 Market Factor Analysis 41
5.1 Porter's Five Force Analysis 41
5.1.1 Threat from a New Entrant 42
5.1.2 Bargaining Power of Buyer 43
5.1.3 Bargaining Power of Supplier 43
5.1.4 Threat from substitute 44
5.1.5 Intensity of Competitive Rivalry 44
5.2 Supply Chain Analysis 46
5.2.1 Raw Material 46
5.2.2 Supplier 47
5.2.3 Manufacturer 48
5.2.4 Distributer 49
5.2.5 Customer 49
5.2.6 Consumer 50
5.2.7 Changes in the supply chain of endoscope devices industry 51
5.2.7.1 Segmentation. 51
5.2.7.2 Agility 51
5.3 Investment Opportunity Analysis 52
5.3.1 Market size (current and future), growth rate and profitability 52
5.3.2 Investment risks 52
5.3.3 3Characteristics of reimbursement scenario in the US 52
5.3.4 US diagnostic imaging reimbursement structure 53
5.3.5 Reimbursement Challenges 53
5.3.6 Strategy from a OEM perspective 54
5.3.7 Market outlook 55
5.3.8 Competitors 55
5.3.9 Projections 55
5.4 Reimbursement scenario 56
5.4.1 3Characteristics of reimbursement scenario in the US 56
5.4.2 US diagnostic imaging reimbursement structure 57
5.4.3 Reimbursement Challenges 57
5.4.4 Strategy from a OEM perspective 57
5.5 Technology Analysis of Market Vendors 58
5.5.1 Synergising two or more imaging technologies 58
5.5.2 Manufacturing 58
5.5.3 Imaging technology advancements 58
5.5.4 Robotic surgery, 3D imaging and disposable endoscopes 59
5.5.5 Assisting algorithms 59
5.5.6 Customization 59
5.5.7 Unmet needs 59
5.6 Number of procedures 60
5.7 Market Potential Analysis 60
6 Global Endoscopy Device market, By Type 62
6.1 Introduction 62
6.2 Flexible Endoscopes 64
6.3 Rigid Endoscopes 64
6.4 Capsule Endoscopes 65
6.5 Surgical Endoscopes 65
6.6 Robot-Assisted Endoscopes 66
7 Global Endoscopy Device market, By Therapy 67
7.1 Introduction 67
7.2 Colonoscopy 68
7.3 Gastroscopy 69
7.4 Arthroscopy 69
7.5 Laparoscopy 70
7.6 Sigmoidoscopy 70
7.7 Endoscopic retrograde cholangiopancreotography 71
7.8 Ureteroscopy 71
7.9 Cystoscopy 72
8 Global Endoscopy Device market, By Treatments & Procedures 73
8.1 Introduction 73
8.2 Abdominal, gynecologic and pelvic organ conditions 75
8.2.1 Hernia Repair 75
8.2.2 Removal Of The Appendi 75
8.2.3 gallbladder 75
8.2.4 spleen 76
8.2.5 uterine fibroids 76
8.2.6 Endometrial tissue 76
8.2.7 ectopic pregnancy 76
8.3 Joint and orthopedic conditions 77
8.3.1 repair of rotator cuff conditions 77
8.3.2 carpal tunnel syndrome 77
8.3.3 Loose bone or cartilage 78
8.3.4 Torn or damaged cartilage 78
8.3.5 Tendons 78
8.3.6 Arthritis 78
8.4 Lower gastrointestinal conditions 79
8.4.1 Removal of colon polyps 79
8.4.2 Treatment of bleeding from the colon 79
8.5 Lung and airway conditions 80
8.5.1 Lung abscess 80
8.5.2 Removal of a foreign object in the airway 80
8.5.3 Opening of a narrowed airway 80
8.6 Upper gastrointestinal conditions 81
8.6.1 Removal of polyps and foreign objects 81
8.6.2 Widening of a narrowed esophagus 81
8.6.3 Treatment of hypertensive lower esophageal sphincter 81
8.6.4 Barrett's esophagus 82
8.6.5 Esophageal cancer 82
8.7 Urinary system conditions 83
8.7.1 Kidney stones 83
9 Global Endoscopy Device market, By Applications 84
9.1 Introduction 84
9.2 Gastrointestinal Endoscopy 85
9.3 Arthroscopy 86
9.4 Obstetrics/Gynecology Endoscopy 86
9.5 Urology Endoscopy 87
9.6 Bronchoscopy 87
9.7 Mediastinoscopy 88
9.8 Otoscopy 88
10 Global Endoscopy Device market, By Accessory & Processors 90
10.1 Introduction 90
10.2 Accessory 92
10.3 Processors 93
11 Global Endoscopy Device market, By Technology 94
11.1 Introduction 94
11.2 Video 95
11.3 Fiber 96
12 Global Endoscopy Device market, By End User 97
12.1 Introduction 97
12.2 .Critical care 98
12.3 Gastroenterologists 99
12.4 General and pediatric surgeons 99
12.5 Obstetricians-gynecologists (Ob/Gyns) 100
12.6 Orthopedic surgeons 100
13 Global Endoscopy Device Market by Region 101
13.1 Americas 103
13.1.1 US 110
13.1.2 Canada 116
13.1.3 Latin America 122
13.2 Europe 128
13.2.1 Germany 135
13.2.2 France 141
13.2.3 Italy 147
13.2.4 Spain 153
13.2.5 UK 159
13.2.6 Rest of Western Europe 165
13.2.7 Eastern Europe 171
13.3 Asia Pacific 177
13.3.1 Japan 184
13.3.2 China 190
13.3.3 India 196
13.3.4 Australia 202
13.3.5 Republic of Korea 208
13.3.6 Rest of Asia-Pacific 214
13.4 Middle East & Africa 221
14 Competitive Landscape 228
14.1 Introduction 228
14.2 Product Mapping 230
15 Company Profiles 231
15.1 Cogentix Medical 231
15.1.1 Company Overview 231
15.1.2 Financials 231
15.1.3 Products 231
15.1.4 Strategy 231
15.1.5 Key Developments 231
15.2 Integrate Endoscopy 232
15.2.1 Company Overview 232
15.2.2 Products 232
15.2.3 Strategy 232
15.2.4 Key Developments 232
15.3 J&J services Inc. 233
15.3.1 Company Overview 233
15.3.2 Financials 233
15.3.3 Products 233
15.3.4 Strategy 233
15.3.5 Key Developments 233
15.4 Shaili Endoscopy 234
15.4.1 Company Overview 234
15.4.2 Financials 234
15.4.3 Products 234
15.4.4 Strategy 234
15.4.5 Key Developments 234
15.5 Interscope Inc. 235
15.5.1 Company Overview 235
15.5.2 Products 235
15.5.3 Strategy 235
15.5.4 Key Developments 235
15.6 Cantel Medical 236
15.6.1 Company Overview 236
15.6.2 Financials 236
15.6.3 Products 236
15.6.4 Strategy 236
15.6.5 Key Developments 236
15.7 Micro-Tech Endoscopy 237
15.7.1 Company Overview 237
15.7.2 Products 237
15.7.3 Strategy 237
15.7.4 Key Developments 237
15.8 Cognetix 238
15.8.1 Company Overview 238
15.8.2 Financials 238
15.8.3 Products 238
15.8.4 Strategy 238
15.8.5 Key Developments 238
15.9 Stryker 239
15.9.1 Company Overview 239
15.9.2 Financials 239
15.9.3 Products 239
15.9.4 Strategy 239
15.9.5 Key Developments 239
15.10 OLYMPUS 240
15.10.1 Financials 240
15.10.2 Products 240
15.10.3 Strategy 240
15.10.4 Key Developments 240
15.11 KARL STORZ Gmbh & Co. KG 241
15.11.1 Company Overview 241
15.11.2 Financials 241
15.11.3 Products 241
15.11.4 Strategy 241
15.11.5 Key Developments 241
15.12 FUJIFILM 242
15.12.1 Company Overview 242
15.12.2 Financials 242
15.12.3 Products 242
15.12.4 Strategy 242
15.12.5 Key Developments 242
15.13 PENTAX MEDICAL 243
15.13.1 Company Overview 243
15.13.2 Financials 243
15.13.3 Products 243
15.13.4 Strategy 243
15.13.5 Key Developments 243
15.14 RICHARD WOLF 244
15.14.1 Company Overview 244
15.14.2 Financials 244
15.14.3 Products 244
15.14.4 Strategy 244
15.14.5 Key Developments 244
16 Conclusion 245
16.1 Key Findings 245
16.1.1 From CEO's View Point 245
16.2 Key companies to watch 246
17 Appendix 247
17.1 Discussion Blue Print 247